2011
DOI: 10.1007/s10529-011-0528-5
|View full text |Cite
|
Sign up to set email alerts
|

Lipopolysaccharide-stimulated activation of murine DC2.4 cells is attenuated by n-butylidenephthalide through suppression of the NF-κB pathway

Abstract: Modulation of dendritic cell (DC) fate and function may be one approach for the treatment of inflammatory and autoimmune diseases. n-Butylidenephthalide (BP), derived from Angelica sinensis, at 40 μg/ml significantly decreased the secretion of interleukin-6 and tumor necrosis factor-α by lipopolysaccharide (LPS)-stimulated activation of cultured murine DC2.4 cells (P<0.01). LPS-induced major histocompatibility complex class II (P<0.05), CD86 (P<0.01) and CD40 (P<0.01) expression on DC2.4 cells was also inhibit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
29
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 31 publications
(32 citation statements)
references
References 23 publications
3
29
0
Order By: Relevance
“…The endotoxin LPS, a molecule found in the outer membrane of bacteria, can trigger stimulation of macrophages and microglial cells by activating various signal transduction pathways including NF-κB [37]. It is known that LPS specifically binds to TLR4 [38]. Accumulating evidence has proved that LPS is the specific ligand of TLR4 [39].…”
Section: Discussionmentioning
confidence: 99%
“…The endotoxin LPS, a molecule found in the outer membrane of bacteria, can trigger stimulation of macrophages and microglial cells by activating various signal transduction pathways including NF-κB [37]. It is known that LPS specifically binds to TLR4 [38]. Accumulating evidence has proved that LPS is the specific ligand of TLR4 [39].…”
Section: Discussionmentioning
confidence: 99%
“…3-n-butylphthalide, another important component of VOAS, could inhibit arachidonic acid metabolism (Lee et al, 2010). Fu et al reported that n-butylidenephthalide derived from AS decreased the secretion of IL-6 and TNF-a (Fu et al, 2011).Our previous studies showed that the content of ligustilide in J-VOAS was significantly higher than that in other kinds of VOAS, and the content of butene ester in C-VOAS was significantly higher than that in other kinds of VOAS (Guo et al, 2010). So the processing method was an important factor, which could affect the efficacy of AS.…”
Section: Change In Relative Content Of Biomarkers and Metabolic Pathwmentioning
confidence: 99%
“…It has been available for treatments such as anemia, female irregular menstruation, cardiovascular disease, amenorrhoea, hypertension, chronic bronchitis, asthma, and rheumatism [12]. n -Butylidenephthalide (Figure 1) is the key bioactive component derived from the chloroform extract of Angelica sinensis herbs, has been confirmed to have a variety of potential pharmacological activities, such as anti-cancer [13][15], anti-angiogenesis [16], anti-inflammatory [17], anti-platelet [18], vasorelaxant [19][21], anti-anginal [22], [23], and anti-atherosclerotic [24] effects. Here, we study that n -butylidenephthalide could be examined as a prophylactic as well as an adjuvant agent for its advantageous effects on PD.…”
Section: Introductionmentioning
confidence: 99%